RESUMO
Objective: To assess the efficacy of Transurethral Microwave Thermotherapy [TUMT] as a treatment modality of Benign Prostate Hyperplasia [BPH]
Patients and Methods: During the period between September 1999 to May 2002 inclusive, sixty six patients were treated with Transurethral Microwave Thermotherapy at KHMC using Prostasoft 2.5 on outpatient basis. Their ages ranged between 55 and 80 years, with a mean of 63 years. The treated prostate weight averaged 60 grams. No anaesthesia was needed, and the patients were discharged home with a Foley's catheter 2-3 hours after the treatment session. The patients were followed in a preassigned schedule for up to 6 months. Madsen scoring system was used to assess the subjective improvement
Results: The Prostate Specific Antigen [PSA] showed a mean reduction of 0.17 ng/ml from the baseline readings. The maximum symptomatic improvement was achieved 3 months after the treatment
Conclusion: TUMT is a safe and effective outpatient form of treating symptomatic BPH, and it is a quite accepted option for patients unfit for a major surgery such as TURP